Genetic Technology Alert. Early Screening Platform for Lung Cancer; Cis Tau Protein Targeting Antibodies for Alzheimer's Diagnosis and Treatment; Gene Targets for Reducing Drug Resistance in Cancer and Infectious Diseases
This issue profiles early screening platform for lung cancer, cis Tau protein targeting antibodies for Alzheimer's diagnosis and treatment, and gene targets for reducing drug resistance in cancer and infectious diseases. Strategic partnership details and some important patents have also been included.
Click headings to expand and collapse
Published: 8 Jun 2012
Tools
Features of this research
Help Desk
For more information and general enquiries, contact Frost & Sullivan near you.
Select a location near you..